Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
ASH position paper: Dietary approaches to lower blood pressure
The Journal of Clinical Hypertension, 06/25/09
Appel LJ et al. – An ASH position paper on dietary approaches to lower blood pressure (BP) focuses on dietary risk factors; race- and age-related risks; effects on nonhypertensive and hypertensive pts; and current challenges of clinical and public health interventions.
Methods- ASH position paper on dietary approaches to lower BP
- Well-established dietary risk factors for elevated BP: excess salt intake, low potassium intake, excess weight, high alcohol consumption, and suboptimal dietary pattern
- African Americans especially sensitive to BP effects of excess salt intake, insufficient potassium intake, and suboptimal diet
- Direct, progressive relationship of BP with cardiovascular-renal diseases throughout usual range of BP, and world epidemic of BP-related disease warrants efforts to reduce BP in nonhypertensive and hypertensive pts
- Lower BP and hypertension delay/prevention for nonhypertensive pts with dietary changes
- Dietary changes serve as initial treatment before drug therapy for uncomplicated stage I hypertension
- Lifestyle modifications can further lower BP in hypertensive pts already on drug therapy
- Current challenge: effective clinical and public health interventions for sustained dietary changes among pts and the general population
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Article Search
Sponsor


See Latest Articles


